Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer risk after splenectomy

L Mellemkjoer1, J H Olsen, M S Linet

  • 1Division for Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.

Cancer
|January 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Genetic Study of Ulcerative Colitis.

Scandinavian journal of gastroenterology·2016
Same author

Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.

Leukemia·2015
Same author

Low-dose aspirin use and the risk of ovarian cancer in Denmark.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Statin use and risk for ovarian cancer: a Danish nationwide case-control study.

British journal of cancer·2014
Same author

Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans.

British journal of cancer·2014
Same author

Risk of liver cancer among US male veterans with cirrhosis, 1969-1996.

British journal of cancer·2012
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Splenectomy after spleen trauma does not increase cancer risk. However, splenectomy for other reasons may be linked to certain cancers, though treatment effects are unclear.

Area of Science:

  • Immunology
  • Oncology
  • Epidemiology

Background:

  • Splenectomy impacts immunologic function.
  • Previous studies on trauma-related splenectomy and cancer risk are limited.
  • Splenectomy in Hodgkin's disease patients may increase secondary leukemia risk.

Purpose of the Study:

  • To evaluate cancer risk in patients who underwent splenectomy due to traumatic spleen rupture.
  • To assess cancer risk following splenectomy for nontraumatic indications.

Main Methods:

  • Identified 1103 patients splenectomized for trauma (1977-1989) via Danish hospital records.
  • Analyzed 5212 additional splenectomized patients for nontraumatic reasons.
  • Linked data to the Danish Cancer Registry to determine cancer occurrence.

Related Experiment Videos

Main Results:

  • No increased cancer risk observed in post-traumatic splenectomy patients (RR=1.0).
  • Follow-up averaged 6.8 years.
  • Potential excesses of specific neoplasms noted in subgroups undergoing splenectomy for nontraumatic reasons, but numbers were small.

Conclusions:

  • Splenectomy for trauma is not associated with increased cancer risk.
  • Splenectomy for nontraumatic reasons may be linked to increased risk for certain cancers.
  • Confounding factors like treatment and lifestyle habits require further investigation.